Ocular Therapeutix (OCUL) Convertible Debt (2019 - 2023)
Historic Convertible Debt for Ocular Therapeutix (OCUL) over the last 5 years, with Q4 2023 value amounting to $9.1 million.
- Ocular Therapeutix's Convertible Debt fell 6821.45% to $9.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $9.1 million, marking a year-over-year decrease of 6821.45%. This contributed to the annual value of $9.1 million for FY2023, which is 6821.45% down from last year.
- According to the latest figures from Q4 2023, Ocular Therapeutix's Convertible Debt is $9.1 million, which was down 6821.45% from $8.8 million recorded in Q3 2023.
- In the past 5 years, Ocular Therapeutix's Convertible Debt registered a high of $30.0 million during Q2 2023, and its lowest value of $8.8 million during Q3 2023.
- Over the past 5 years, Ocular Therapeutix's median Convertible Debt value was $25.3 million (recorded in 2020), while the average stood at $24.3 million.
- Its Convertible Debt has fluctuated over the past 5 years, first soared by 1026.86% in 2020, then tumbled by 6886.54% in 2023.
- Ocular Therapeutix's Convertible Debt (Quarter) stood at $24.3 million in 2019, then grew by 0.01% to $24.3 million in 2020, then increased by 8.75% to $26.4 million in 2021, then increased by 8.75% to $28.7 million in 2022, then tumbled by 68.21% to $9.1 million in 2023.
- Its Convertible Debt was $9.1 million in Q4 2023, compared to $8.8 million in Q3 2023 and $30.0 million in Q2 2023.